The Trump Administration Reclassifies Medical Marijuana: What It Means and Doesn’t Mean
In a significant shift in the country’s stance on marijuana, Acting Attorney General Todd Blanche has signed an order reclassifying state-licensed medical marijuana from a Schedule I to a Schedule III drug. This move does not make marijuana legal in the US, but it does pave the way for more research into its effects and potential medical benefits.
The reclassification is a major step forward, as it will enable more targeted and rigorous research into marijuana’s safety and efficacy. This, in turn, will expand patients’ access to treatments and empower doctors to make better-informed healthcare decisions.
Despite the reclassification, marijuana remains illegal under federal law, and its legality will not change in states that allow medical and recreational use. Additionally, the decision will not affect individuals who have been convicted of pot-related offenses.
The move is significant, as it marks a major turning point in the country’s evolution with marijuana over the past two decades. Support for legalizing marijuana has doubled since 2000, and nearly 80% of Americans now live in a county with at least one legal marijuana dispensary. The legal pot market has more than tripled over the past decade.
The reclassification is a result of years of advocacy by researchers, lawmakers, and advocacy groups. The decision is seen as a major victory, as it will allow scientists to study the potential harms and benefits of a drug that millions of Americans regularly use.
The Controlled Substances Act, passed in 1970, created tiered categories for drugs based on their benefits and potential risks. Marijuana was initially placed in Schedule I, a category for drugs with “no currently accepted medical use and a high potential for abuse.” However, despite a substantial body of scientific research showing marijuana’s potential medical benefits, it remained in Schedule I for 56 years.
The tide began to turn in 2024, when former President Joe Biden started the formal process of changing marijuana’s classification. Delays and opposition from Republicans in Congress meant that the Biden administration was unable to complete the change before the end of his term. President Trump signed an executive order in December calling on his administration to expedite marijuana’s rescheduling.
While there are still some groups that oppose rescheduling marijuana, polls show that an overwhelming majority of Americans support medical marijuana. The reclassification is seen as a major step forward in recognizing the medical use of marijuana and expanding patients’ access to treatments.
